Cover Page
Cover Page - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Mar. 31, 2024 | Jun. 30, 2023 | |
Document Information [Line Items] | |||
Document Type | 10-K/A | ||
Amendment Flag | false | ||
Document Period End Date | Dec. 31, 2023 | ||
Document Fiscal Year Focus | 2023 | ||
Document Fiscal Period Focus | FY | ||
Entity Registrant Name | Eliem Therapeutics, Inc. | ||
Entity Central Index Key | 0001768446 | ||
Current Fiscal Year End Date | --12-31 | ||
Entity Filer Category | Non-accelerated Filer | ||
Entity Shell Company | false | ||
Entity Current Reporting Status | Yes | ||
Entity Interactive Data Current | Yes | ||
Entity Small Business | true | ||
Entity Emerging Growth Company | true | ||
Entity Ex Transition Period | false | ||
Entity File Number | 001-40708 | ||
Entity Incorporation, State or Country Code | DE | ||
Entity Tax Identification Number | 83-2273741 | ||
Entity Address, Address Line One | PMB #117 | ||
Entity Address, Address Line Two | 2801 Centerville Road 1st Floor | ||
Entity Address, City or Town | Wilmington | ||
Entity Address, State or Province | DE | ||
Entity Address, Postal Zip Code | 19808-1609 | ||
City Area Code | 1-877 | ||
Local Phone Number | 354-3689 | ||
Document Annual Report | true | ||
Document Transition Report | false | ||
Title of 12(b) Security | Common Stock, par value $0.0001 | ||
No Trading Symbol Flag | true | ||
Security Exchange Name | NASDAQ | ||
Entity Common Stock, Shares Outstanding | 27,723,824 | ||
Document Financial Statement Error Correction [Flag] | false | ||
Entity Well-known Seasoned Issuer | No | ||
Entity Voluntary Filers | No | ||
ICFR Auditor Attestation Flag | false | ||
Auditor Name | PricewaterhouseCoopers LLP | ||
Auditor Location | Seattle, WA | ||
Auditor Firm ID | 238 | ||
Entity Public Float | $ 13.2 |